Immune response in COVID-19: what is next?
Abstract The coronavirus disease 2019 (COVID-19) has been a global pandemic for more
than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A …
than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A …
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Oncogenesis is associated with intestinal dysbiosis, and stool shotgun metagenomic
sequencing in individuals with this condition might constitute a non-invasive approach for …
sequencing in individuals with this condition might constitute a non-invasive approach for …
Learning through a pandemic: the current state of knowledge on COVID-19 and cancer
The ongoing coronavirus disease 2019 (COVID-19) pandemic has left patients with current
or past history of cancer facing disparate consequences at every stage of the cancer …
or past history of cancer facing disparate consequences at every stage of the cancer …
COVID‐19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B‐lymphocytosis; humoural and cellular immunity
Y Shen, JA Freeman, J Holland… - British Journal of …, 2022 - Wiley Online Library
Chronic lymphocytic leukaemia (CLL) is associated with immunocompromise and high risk
of severe COVID‐19 disease and mortality. Monoclonal B‐cell lymphocytosis (MBL) patients …
of severe COVID‐19 disease and mortality. Monoclonal B‐cell lymphocytosis (MBL) patients …
Prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at high viral loads among hospitalized immunocompromised persons living …
Background We assessed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
RNA shedding duration and magnitude among persons living with human …
RNA shedding duration and magnitude among persons living with human …
[PDF][PDF] Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
Background Immunocompromised individuals are highly susceptible to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Whether vaccine-induced …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Whether vaccine-induced …
[HTML][HTML] Prolonged shedding of SARS-CoV-2 at high viral load amongst hospitalised immunocompromised persons living with HIV in South Africa
Purpose There is limited information on SARS-CoV-2 shedding duration amongst persons
living with HIV (PLWH). We hypothesised that PLWH shed SARS-CoV-2 for longer periods …
living with HIV (PLWH). We hypothesised that PLWH shed SARS-CoV-2 for longer periods …
Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients
P Heudel, B Favier, ML Solodky, S Assaad… - European Journal of …, 2022 - Elsevier
Background Patients with cancer are at high risk of severe or lethal COVID-19. The impact of
SARS-COV-2 vaccination on the risk of developing COVID-19 was investigated in an …
SARS-COV-2 vaccination on the risk of developing COVID-19 was investigated in an …
Comprehensive oncogenic features of coronavirus receptors in glioblastoma multiforme
A Chen, W Zhao, X Li, G Sun, Z Ma, L Peng… - Frontiers in …, 2022 - frontiersin.org
The COVID-19 pandemic caused by SARS-CoV-2 infection has placed health systems
under excessive pressure and especially elderly people with cancer. Glioblastoma …
under excessive pressure and especially elderly people with cancer. Glioblastoma …
Long-range enhancement of N501Y-endowed mouse infectivity of SARS-CoV-2 by the non-RBD mutations of Ins215KLRS and H655Y
Y Zhu, W Zhou, Z Niu, J Sun, Z Zhang, Q Li, Y Zheng… - Biology direct, 2022 - Springer
Background Rodents, such as mice, are vulnerable targets, and potential intermediate hosts,
of SARS-CoV-2 variants of concern, including Alpha, Beta, Gamma, and Omicron. N501Y in …
of SARS-CoV-2 variants of concern, including Alpha, Beta, Gamma, and Omicron. N501Y in …